Filter
4813
Filtered Results: 4813
Text search:
Vaccines
Featured
Recommendations
520
New Publications
1232
Language
Document type
No document type
2186
Studies & Reports
812
Guidelines
686
Fact sheets
285
Manuals
233
Strategic & Response Plan
229
Situation Updates
99
Training Material
78
Resource Platforms
77
Videos
59
Infographics
36
Brochures
18
Online Courses
14
App
1
Countries / Regions
Global
199
India
191
Kenya
131
Nigeria
107
Liberia
106
Congo, Democratic Republic of
105
Sierra Leone
104
South Africa
93
Latin America and the Carribbean
92
Africa
88
Uganda
84
Ethiopia
84
Nepal
69
Western and Central Europe
66
Brazil
61
Zambia
58
Ghana
57
Syria
56
Bangladesh
55
Malawi
54
Rwanda
53
Tanzania
53
Germany
49
Ukraine
46
West and Central Africa
46
Russia
44
Haiti
42
Middle East and North Africa
42
East and Southern Africa
42
Myanmar / Burma
41
South Sudan
39
Philippines
38
Guinea
36
Mozambique
34
Senegal
32
Zimbabwe
32
Yemen
32
Namibia
31
Lesotho
29
South–East Asia Region
29
Venezuela
28
Pakistan
26
Eastern Europe
22
Asia
21
Cameroon
20
Argentina
20
Burkina Faso
19
Cambodia
19
Eastern Europe and Central Asia
19
Botswana
18
Indonesia
17
Colombia
16
Sudan
16
Afghanistan
15
Lebanon
15
Peru
14
Niger
13
Central African Republic
13
Western Pacific Region
12
Paraguay
12
Angola
12
Somalia
12
Benin
11
Madagascar
11
Chile
10
Mali
10
Eswatini/ Swaziland
10
China
9
Jordan
8
Ecuador
8
USA
7
Guinea-Bissau
7
Côte d’Ivoire / Ivory Coast
7
Vietnam
7
Mexico
6
Laos
6
Burundi
6
United Kingdom
6
Bolivia
6
Moldova
6
Chad
6
Iraq
6
Turkey
5
Togo
5
Saudi Arabia
5
Papua New Guinea
5
Thailand
4
El Salvador
4
Iran
4
Spain
4
Albania
3
Congo-Brazzaville
3
France
3
Nicaragua
3
Egypt
3
Palestine
3
Honduras
3
Libya
3
North Macedonia
2
Tajikistan
2
Timor Leste/ East Timor
2
Kazakhstan
2
Fiji
2
Malaysia
2
Morocco
2
Qatar
2
Bulgaria
2
North America
2
Turkmenistan
2
Japan
2
Tunisia
2
South Korea
2
Belarus
2
Southern Africa
2
Sri Lanka
2
Georgia
2
Guatemala
2
Gambia
1
Canada
1
Kyrgyzstan
1
Uzbekistan
1
Mongolia
1
Mauritania
1
Dominican Republic
1
Hungary
1
Gabon
1
Uruguay
1
Jamaica
1
Denmark
1
Maldives
1
Mauritius
1
Portugal
1
French Guyana
1
Israel
1
Djibouti
1
Romania
1
Slovakia
1
Poland
1
Bhutan
1
Solomon Islands
1
Cuba
1
Authors & Publishers
Publication Years
Category
Countries
1919
Clinical Guidelines
395
Women & Child Health
221
Public Health
200
Key Resources
143
Pharmacy & Technologies
54
Capacity Building
45
Annual Report MEDBOX
2
Toolboxes
COVID-19
1018
Rapid Response
258
Ebola
224
HIV
209
TB
197
AMR
181
NTDs
132
Conflict
116
Pharmacy
114
Refugee
105
Planetary Health
92
Global Health Education
90
Polio
88
Health Financing Toolbox
84
Caregiver
78
Cholera
67
Zika
65
Mental Health
62
Natural Hazards
45
Disability
25
NCDs
25
Specific Hazards
14
Typhoon
3
Health Financing
2
South Sudan
1
African Union and the Africa Centers for Disease Control and Prevention’s Africa Regulatory Taskforce has endorsed the Emergency Used Authorization for Janssen COVID-19 Vaccine
10 March 2021
26 March 2021
If you have already had COVID-19 do you still need both doses of the vaccine? Do these vaccines protect you against infection? Do they protect us against variants? WHO’s Dr Katherine O’Brien answers these questions in Science in 5 this week.
31 March 2021
This article is part of a series of explainers on vaccine development and distribution. Learn more about vaccines – from how they work and how they’re made to ensuring safety and equitable access – in WHO’s Vaccines Explained series.
COVID-19 vaccines are safe, and getting v...
“Guide to facilitate the implementation of the WHO/UNICEF “Guidance on developing a national deployment and vaccination plan for COVID-19 vaccines” for Africa
t contains action-oriented lists of critical topics to address and checklists tailored to the context of African Union Member States.
...
How much protection does the current batch of COVID-19 vaccines provide us? Would you need a booster shot for new variants? What does science and evidence tell us about mass gatherings and the spread of COVID-19?
WHO’s Chief Scientist Dr Soumya Swaminathan explains in Science in 5 this week.
What is the guidance for vaccination of women with breastfeeding infants, women who are pregnant or planning to get pregnant and women who are menstruating? What about vaccines and fertility? WHO’s Dr Soumya Swaminathan explains in Science in 5.
Why does WHO recommend at this time, in June 2021, that vaccinating children is not a priority? When would their vaccination be prioritized? How is safety of these vaccines ensured? WHO’s Chief Scientist Dr Soumya Swaminathan explains in Science in 5.
Do the current batch of approved vaccines protect us from the Delta variant? What is the level of protection? If you can still get infected even after being fully vaccinated, then why should we vaccinate? WHO’s Chief Scientist Dr Soumya Swaminathan explains in Science in 5.
The overall goal of this strategy is to ensure accurate understanding of the
benefits of covid-19 vaccination and alleviate apprehension about the vaccine, to ensure its acceptance and encourage uptake across various audiences.
Objectives
x Create demand, promote acceptability and accessibility o...
This guidance document provides basic principles for a spokesperson of any health authority on how to respond to vocal vaccine deniers. The suggestions are based on psychological research on persuasion, on research in public health, communication studies and on WHO risk communication guidelines.
The CVIC tool is the WHO-UNICEF tool designed to assist countries in the process of planning and costing COVID-19 vaccination. The aim of this course is to demonstrate the use of the CVIC tool. The course is targeting national programme managers and personnel who have been involved in the costing, b...
This inter-agency guidance document aims to supplement the COVAX demand creation package for COVID-19 vaccines with key considerations for humanitarian contexts and marginalized populations with specific access and communication needs.
21 Sept.2021
updated version: 04/10/2021
Information about vaccine administration
Development of one or more vaccines for Neisseria gonorrhoeae is an important objective for sexual and reproductive health worldwide, and for the fight against antimicrobial resistance.
WHO preferred product characteristics (PPCs) provide strategic guidance as to WHO’s preferences for new vacci...
Overview
16 Dec 2021. This interim guidance pertains to heterologous primary and heterologous boosting schedules of Covid-19 vaccines. It focuses on heterologous schedules combining multiple vaccine platforms (e.g. a vectored vaccine followed by an mRNA vaccine).
17 Febr. 2022. As part of the “Strategy to Achieve Global COVID-19 Vaccination by mid-2022”, global targets of 40% population coverage by end of 2021 and 70% coverage by June 2022 have been set by the World Health Organization (WHO), to successfully prevent severe illness and deaths, minimize so...
